Search Results 121-130 of 217 for ✔위너가입코드 [원탑보증.com/가입코드 111] sbc가입코드 ✔

  1. A Study of Tucatinib Plus Trastuzumab Deruxtecan in HER2+ Breast Cancer - Mayo Clinic

    This trial studies how well the drug tucatinib works when given with trastuzumab deruxtecan. It will also look at what side effects happen when these drugs are ...

  2. Tafasitamab + Lenalidomide + R-CHOP Versus R-CHOP in Newly Diagnosed High-intermediate and High Risk DLBCL Patients - Mayo Clinic

    About this study. The purpose of this study is to compare the effectiveness and safety of the humanized monoclonal anti CD19 antibody tafasitamab plus ...

  3. SEVENFACT® for Bleeding Events in Hemophilia With Inhibitors - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  4. LEGEND Study: A Phase 1/2 Study of EG-70 as an Intravesical Administration to Patients With BCG Unresponsive Non-Muscle Invasive Bladder Cancer (NMIBC) and High-Risk NMIBC Patients Who Are BCG Naïve or Received Incomplete BCG Treatment - Mayo Clinic

    LEGEND Study: A Phase 1/2 Study of EG-70 as an Intravesical Administration to Patients With BCG Unresponsive Non-Muscle Invasive Bladder Cancer (NMIBC) and High ...

  5. A Study to Evaluate At Home Administration of Pertuzumab Combined with Trastuzumab to Treat Patients with HER2-Positive Breast Cancer During COVID-19 Pandemic - Mayo Clinic

    A Study to Evaluate At Home Administration of Pertuzumab Combined with Trastuzumab to Treat Patients with HER2-Positive Breast Cancer During COVID-19 Pandemic.

  6. Study of RYZ101 in Combination With SoC in Subjects With SSTR+ ES-SCLC - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  7. Efficacy and Safety of Seralutinib in Adult Subjects With PAH - Mayo Clinic

    The primary objective of the study is to determine the effect of seralutinib on improving exercise capacity in subjects with WHO Group 1 PAH who are FC II or ...

  8. Single-Ascending Dose Study of JK07 in Subjects With HFpEF - Mayo Clinic

    The purpose of this study is to assess the safety and tolerability profile of JK07, administered intravenously, according to protocol-defined dosing regimen.

  9. Enhancing the Natriuretic Peptide System in HFpEF - Mayo Clinic

    The purpose of this study is to look at the differences in how individuals with HFpEF-CKD and HFpEF-EI's bodies function using Sacubatril/valsartan (Entresto 97 ...

  10. Donate to Mayo Clinic

    Mayo Clinic's leadership position in patient care, research and education depends on visionary benefactors like you. Your gift today will touch the lives of ...